Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 46.18
+2.08 (4.72%)
May 14, 2026, 5:35 PM CET
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of €2.14 billion as of May 14, 2026. Its market cap has increased by 1,345.99% in one year.
Market Cap
2.14B
Enterprise Value
2.18B
Revenue
32.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
€46.18
Market Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 66.13M to 2.14B, an increase of 3,134.21%. That is a compound annual growth rate of 29.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 2.14B | 126.70% |
| Dec 31, 2025 | 943.39M | 558.09% |
| Dec 31, 2024 | 143.35M | -54.17% |
| Dec 29, 2023 | 312.82M | 147.96% |
| Dec 30, 2022 | 126.16M | -50.42% |
| Dec 31, 2021 | 254.47M | -46.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 8.31B |
| MedinCell | 1.01B |
| DBV Technologies | 1.00B |
| Inventiva | 992.84M |
| Valneva SE | 488.91M |
| Genfit | 443.18M |
| Cellectis | 257.55M |
| Transgene | 232.80M |